Esperion Therapeutics, Inc. (ESPR) — 10-K Filings
All 10-K filings from Esperion Therapeutics, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Esperion Therapeutics Files 2024 10-K
— Mar 7, 2025 Risk: medium
Esperion Therapeutics, Inc. filed its 2024 10-K on March 7, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly HDL Therapeutics -
Esperion Therapeutics, Inc. Files 2023 Annual Report on Form 10-K
— Feb 27, 2024 Risk:
Esperion Therapeutics, Inc. (ESPR) filed a Annual Report (10-K) with the SEC on February 27, 2024. Esperion Therapeutics reported its 2023 fiscal year results,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX